Open AccessHigh rate of event-free survival at 24 months with everolimus/RCHOP for untreated diffuse large B-cell lymphoma: updated results from NCCTG N1085 (Alliance)
Author(s) -
Thomas E. Witzig,
Betsy LaPlant,
Thomas M. Habermann,
Ellen D. McPhail,
David J. Inwards,
Iva. Micallef,
Joseph P. Colgan,
G. S. Nowakowski,
Stephen M. Ansell,
Patrick B. Johnston
Publication year - 2017
Publication title -
blood cancer journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.607
H-Index - 51
ISSN - 2044-5385
DOI - 10.1038/bcj.2017.57
Subject(s) - everolimus , diffuse large b cell lymphoma , medicine , lymphoma , alliance , overall survival , oncology , political science , law
High rate of event-free survival at 24 months with everolimus/RCHOP for untreated diffuse large B-cell lymphoma: updated results from NCCTG N1085 (Alliance)
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom